NASDAQ: LICNLichen International Ltd Stock
$4.76-0.25 (-4.99%)
Updated Sep 15, 2025
LICN Price
$4.76
Fair Value Price
$3.83
Market Cap
$2.35M
52 Week Low
$2.60
52 Week High
$462.00
P/E
-0.14x
P/B
0.03x
P/S
0.15x
PEG
N/A
Dividend Yield
N/A
Revenue
$41.48M
Earnings
-$6.14M
Gross Margin
61.9%
Operating Margin
-10.1%
Profit Margin
-14.8%
Debt to Equity
0.06
Operating Cash Flow
-$6M
Beta
1.32
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
LICN Overview
Lichen International Ltd. engages in providing financial and taxation solutions. It also offers educational support, and software and maintenance services. The company was founded by Li Ya on April 13, 2016 and is headquartered in Jinjiang, China.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine LICN's potential to beat the market
- LICN doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Business Service
Industry Rating
C
LICN
RankedUnranked of 33
RankedUnranked of 33
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.53 | B | |
| $6.70 | B | |
| $87.97 | B |
Be the first to know about important LICN news, forecast changes, insider trades & much more!
LICN News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how LICN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
LICN ($4.76) is overvalued by 24.2% relative to our estimate of its Fair Value price of $3.83 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
LICN ($4.76) is not significantly undervalued (24.2%) relative to our estimate of its Fair Value price of $3.83 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
LICN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more LICN due diligence checks available for Premium users.
Valuation
LICN fair value
Fair Value of LICN stock based on Discounted Cash Flow (DCF)
Price
$4.76
Fair Value
$3.83
Overvalued by
24.20%
LICN ($4.76) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
LICN ($4.76) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
LICN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
LICN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.14x
Industry
28.55x
Market
37.32x
LICN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.03x
Industry
4.75x
LICN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
LICN's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
LICN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
LICN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$79.8M
Liabilities
$4.3M
Debt to equity
0.06
LICN's short-term assets ($34.01M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LICN's short-term assets ($34.01M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LICN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
LICN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
LICN vs Specialty Business Service Stocks
Lichen International Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.